This report profiles 18 of the largest and fastest growing domestic Chinese pharmaceutical companies by examining their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare industry. While it is not easy to get summarized company-specific information on domestic Chinese pharmaceutical companies, ISR has done the legwork for you. In this report we profile 18 of the largest and fastest growing domestic Chinese pharmaceutical companies. We profile their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. We think you’ll find this report to be a superior source of information on some of China’s largest and fastest growing pharmaceutical companies. The companies profiled in this report accounted for nearly $15billion USD in revenue in 2010 and over $1.2billion USD in net income. Companies Profiled: 3SBio American Oriental Bioengineering Beijing Double-crane Pharmaceutical Company Beijing Tongrentang China Buchang Pharmaceutical Group China Resources Sanjiu Medical & Pharmaceutical Company Guangzhou Pharmaceutical Holdings Harbin Pharmaceutical Group North China Pharmaceutical Group Qilu Pharmaceutical Company Shandong Xinhua Pharmaceutical Company Shanghai Fosun Pharmaceutical Group Shanghai Pharmaceutical Group Shineway Simcere Pharmaceutical Group Sinovac Biotech Yangtze River Pharmaceutical Group Zhejiang Medicine Company